Eli Lilly and Company (NYSE:LLY) , which has been around since the late 1800s, has built a strong track record in developing and selling drugs for diabetes, cancer, and immunology, including ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.1% in the afternoon session after the company halted a mid-stage clinical trial for its experimental drug, bimagrumab, which was ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their GLP-1 products. Lilly markets its dual GIP and GLP-1 receptor agonist, ...

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is ...

Porsche already builds Turbo-branded versions of its fully electric Taycan and Macan EV. But now the German automaker is reversing the equation, with an electrified version of the Porsche 911 Turbo S.

The move prompted Chief Market Strategist Shay Boloor of Futurum Equities to declare that a company like Lilly “doesn’t issue a 40-year bond unless they’re setting up for something BIG.” The ...

If your info appears on a people-search site, you can request its removal—but chances are, that's just the tip of the iceberg. For broader data removal, services like Incogni or Optery can help. I ...

Eli Lilly (NYSE:LLY) CEO David Ricks and other top executives have bought nearly $2.9M worth of company stock over the past few days as the Indiana-based drugmaker witnessed a rare selloff last week ...

Eli Lilly stock sank after its second-quarter report due to underwhelming results for a key weight loss drug in its pipeline. Eli Lilly actually posted strong sales and earnings results in Q2 and ...